Clinical outcomes of patients with gastrointestinal stromal tumor in phase I clinical trials

BACKGROUND: The prognosis of patients with gastrointestinal stromal tumor (GIST) after the failure of standard therapies is poor with supportive care alone. Guidelines recommend clinical trials, and patients with good performance status following standard therapies are often eligible for phase I cli...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:BMC Cancer
Auteurs principaux: Nagatani, Yoshiaki, Shitara, Kohei, Bando, Hideaki, Kuboki, Yasutoshi, Okamoto, Wataru, Kojima, Takashi, Yoshino, Takayuki, Nishida, Toshirou, Ohtsu, Atushi, Doi, Toshihiko
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2016
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5109764/
https://ncbi.nlm.nih.gov/pubmed/27842521
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-016-2939-0
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires